Oregon took a leap into the psychedelic unknown when voters approved regulated psilocybin services nearly six years ago to treat addiction, depression and other illnesses. Since then, thousands of ...

Compass Pathways announced that its investigational psilocybin treatment has successfully met its primary endpoint in a Phase 3 trial in depression.

Mushcanyon 10X is a high-potency functional mushroom blend designed to elevate focus, energy, and overall wellness naturally. Formulated with powerful adaptogenic mushrooms, it supports peak mental ...